The 10 most innovative healthcare solution providers 2018

www.insightssuccess.com
Med A-Z:A Novel Approach towards Improving
Medical Business Processes
Care & Cure
The Next Frontier of Innovation
in the Pharmaceutical industry
Solution Providers 2018
Most Innovative
The
HEALTHCARE
Satish Kumar
CEO
Med A-Z
Agri Tech
Agriculture Biotechnology:
Revolutionizing Agriculture
Process Globally
August 2018
Company of the Month
Paul Black
CEO & Board Member
Allscripts

You are the front lines
of health care.
We’ll be your wings

et’s head into the time where an entire population of a village had to leave their houses and
Leverything earned, fearing a single epidemic. A time, when there were no diagnosing techniques or
surgeries available, to fulfill our wish of a healthy and long life. Imagine, what if we had to face it
now? What if there are no hospitals or other advanced health care institutes to ensure our safety and well-
being? This thought surely disturbs our comfort zone doesn’t it?
th
From the 17 century to the generation X, healthcare has undergone through an enormous change. Thanks
to incredible innovations that has transformed the arena and eventually human lives. The health care
industry is experiencing the most rapid pace of innovation ever. This shift has been driven with new
innovations presenting tantalizing value for health care. And they are serving the purpose of healthcare i.e.
care in the best possible way.
Be it the big x-ray machines used in the hospitals for diagnosis or the laser beams resolving eye problems
every innovation has reduced the unrequired time frame. They are making healthcare easier and efficient
than ever before and that too in a real-time. However, some studies also show that the innovations have
raised the bar of expectations of customers.
Customers are hoping to get cured as soon as possible which not a cake walk for crowded systems
hospitals. Patient satisfaction has become pertinent for hospitals for a few reasons: Consumers are being
more selective as they look for the most affordable provider; patient loyalty is at a premium due to tough
competition among hospitals; and CMS’ value-based purchasing now factors patient experience into
Medicare reimbursements.
Editor’s Note
Reforming the
Benchmarks of
Healthcare

The U.S. health care community converged at the 2018 HIMSS conference in Las Vegas earlier this
month, where health care leaders, vendors and regulators confronted the challenges of riding the
currents of innovation while consistently and strategically prioritizing patients and providing them
with greater knowledge and more control of their health care.
Although hospitals are using a number of different strategies to improve this area, such as employing
care navigators, care teams or even chief patient experience officers. As the health care businesses
continue to make strategic acquisitions and vertical integrations, there is a greater need for smooth
transitions of IT operations across those integrations while maintaining reliable and transparent
services to those on the front lines of care delivery. Information technology is also playing a role in
coordinating care to improve the patient experience.
Considering all this factors, Insighs Success has curated a list of The 10 Most Innovative
Healthcare Solution Providers 2018 which are reforming the benchmarks of Healthcare with their
ground-breaking innovation and real-time assistance.
Featuring as the Cover Story we have MedAZ which develops and markets information technology
solutions to the healthcare industry. With years of combined software development experience and 8
years of client feedback, Med A-Z has accumulated rich experience in supporting its worldwide
clients with its process building tools.
We have also featured Abionic SA is a Swiss medtech company headquartered in Lausanne that
specializes in medical devices and in vitro diagnostics; AdhereTech, its program increases adherence
to specialty medications by approximately 20%; Allscripts is leading the healthcare IT movement
into the value-enabled world of tomorrow; CereSoft, Inc. that provides application service provider
based data capture solutions for the healthcare industry; eData Platform, an innovative
technologically advanced platform that enables an organization to deploy a suite of tailored business
applications; NextShift is a healthcare technology innovation company committed to better
healthcare by working with its clients and partners to develop breakthrough digital solutions;
Rethink is a global health technology company providing cloud-based treatment tools, training and
clinical supports for individuals with developmental disabilities and their caregivers; Vee
Technologies is a global business process management firm. The company provides strategic
services to leading global businesses that help them reach their full potential.
In addition to this, we have also included enriching articles penned by industry leaders and our in-
house editorial team.
Let’s flip shall we?
Kedar Kulkarni

Med A-Z:A Novel Approach towards Improving Medical
Business Processes
Allscripts
Building Open and Connected
Communities of Health
COVER
STORY
10
18

CONTENTS
22
Abionic SA
Revolutionizing the
World of In Vitro
Diagnostics
AdhereTech
Assisting Patients to
take Medications on Time
24
Director’s Viewpoint
Why Supermarkets
Need To Talk To
Millennials In
Their Language
34
Expert’s Outlook
4 Trends That Will Make
Language Solutions A Big
Part Of Biotech And
Globalization
44

Care & Cure
The Next Frontier
of Innovation in the
Pharmaceutical
Industry
30
CereSoft:
Energizing Healthcare
Cash Flow
32
eData Platform:
The Future of
Healthcare Software
NextShift:
Creating Better Healthcare
36 42
Rethink:
Empowering Individuals
with Developmental Disabilities
50
Vee Technologies:
Streamlined, Multi-faceted
Healthcare Management in
Your Hands
Market Dashboard
Social Marketing for
Pharma Industry
Articles
26
Agri Tech
Agriculture Biotechnology:
Revolutionizing Agriculture
Process Globally
38 46

sales@insightssuccess.com
Corporate Ofces:
August, 2018
Database Management Stella Andrew
Technology Consultant David Stokes
Circulation Managers Robert, Tanaji
Research Analyst Chidiebere Moses
Steve, Joe, Alan, Vishal
Anish MillerManaging Editor
Jenny Fernandes
Art & Design Director Amol Kamble
Associate Designer Tejas Kulkarni
Visualiser David King
Senior Sales Manager Passi D.
Business Development Executives
Marketing Manager John Matthew
Executive Editor
Assistant Editors
Shubham Khampariya
Art & Picture Editors BelinPaul
Co-designer Aparna Vanzul
KhannaJayant
Peter CollinsBusiness Development Manager
Sales Executives
David, Kevin, Mark, Manish
SME-SMO Executives
Prashant Chevale, Uma Dhenge, Gemson, Irfan
Online Marketing Strategists
Alina Sege, Shubham, Vaibhav K
Digital Marketing Manager Marry D’Souza
Technical Specialists Amar, Pratiksha
Technical Head Jacob Smile
Copyright © 2018 Insights Success, All rights reserved. The content and images used in this magazine should not be reproduced or transmitted in
any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior permission from Insights Success.
Reprint rights remain solely with Insights Success.
Follow us on : www.facebook.com/insightssuccess/ www.twitter.com/insightssuccess
We are also available on :
Insights Success Media Tech LLC
555 Metro Place North, Suite 100,
Dublin, OH 43017, United States
Phone - (614)-602-1754
Email: info@insightssuccess.com
For Subscription: www.insightssuccess.com
Insights Success Media and Technology Pvt. Ltd.
Off. No. 513 & 510, 5th Flr., Rainbow Plaza, Shivar Chowk,
Pimple Saudagar, Pune, Maharashtra 411017
Phone - India: +91 7410079881/ 82/ 83/ 84/ 85
Email: info@insightssuccess.in
For Subscription: www.insightssuccess.in
Kedar Kulkarni
Contributing Editors
Abhishaj Sajeev
Hitesh Dhamani
Editor-in-Chief Pooja M. Bansal

Med A-Z:A Novel Approach towards Improving Medical Business Processes
We help healthcare providers
manage the business of
medicine while they
concentrate on the
practice of Medicine.

At Med A-Z, it’s our goal to leverage technology
to provide these services in a way that is
totally secure, reliable and easy-to-use.
The technological revolution has emerged as an
enabling factor in the development of almost
every sector. On a similar note, the healthcare
industry is facing numerous challenges in today’s
dynamic business environment, be it clinical, non-
clinical or operational processes in hospitals. Hence, the
industry is embracing digital transformation and making
significant investments in processes and technologies to
cut down costs, increase access to care delivery, and
improve medical care. A team of information technology
professionals and clinical experts, with an objective to
improve medical business processes formed ,Med A-Z
as a wholly owned subsidiary of Koni Ameri Tech
Services, Inc.
With 400 years of combined software development
experience and 8 years of client feedback, Med A-Z has
accumulated rich experience in supporting its worldwide
clients with its process building tools. Its goal is to
leverage technology in providing their services in a
totally secure, reliable and simplified manner. The
company targets ambulatory practices and outpatient
clinics and is part of a 4 product strategy that targets the
healthcare marketplace.
An Integrated Healthcare System
Med A-Z started with a simple vision, to help doctors
deliver high quality care to the patients, while ensuring
they get paid for everything they do. It helps healthcare
providers manage their businesses by enabling them to
concentrate on their patients. It has its elevator pitch for
their customer which states ‘We help you in taking care
of your business of medicine, while you take care of the
practice of medicine.’
Med A-Z offers a fully integrated solution for patient
care called ‘Med A-Z Complete’, which comprises of
three modules including Electronic Health Records
(EHR), Revenue Cycle Management (RCM), and
Practice Management. The platform is designed around
the concept of data interoperability, which creates the
ability to link disparate health management systems,
enabling healthcare providers to exchange electronic
healthcare data with ease, and eventually improving
patient care. The Med A-Z Complete platform is
designed to address key challenges like data operability
between systems, robust data security, and outcome
based patient care.
®
In addition to these solutions, MAI EDEN, an analytics
and population health management software, is the
company’s newly evolved platform. It combines cutting
edge analytical tools with support and services to help
the healthcare industry. It also delivers value-based-care,
while improving clinical outcomes and provides cost
effective care for patients. The other products includes
MAI EDEN for population management and clinical and
®
quality benchmarks, MAI REMINDERS for automated
®
reminders by text, phone and email, MAI PRACTICUM
®
for recording and tracking, Practicum for nursing and
other specialties and MAI DOC for document
®
management using latest digitization technologies for
easy access like QR codes.
Ingenuity at its Best
It is ingenuity that takes particular person one step ahead
of the others. After serving in parent company, Koni
Ameri Tech Services as a consultant, nowSatish Kumar
hold the role of in Med A-Z. Satish hasCEO of APAC
®
played a key role in developing MAI EDEN and rolling
it out to the customers in US.
According to Satish, most EHRs are designed to work on
the ‘fee-for-service’ model, whereas the focus is shifting
toward ‘value based care’ model. The ground is shifting
®
from cure to prevention. Med A-Z and MAI EDEN help

We are a fully integrated EHR,
Practice Management and billing solution.
providers focus on just that. He states that the focus is
®
now to take Med A-Z Complete along with MAI EDEN
across Middle East, South Africa with plans to roll out
the products in India in early 2019.
From Challenged Sensed to its Solution
According to Vasu S. Iyengar, the Founder and CTO,
Med A-Z sensed challenges in the healthcare industry
which were on 2 fronts. First challenge was to provide
quality care to the patients. The second challenge was of
enterprises on handling revenues needed to run their
business, in the form of claims and reimbursements. In
his views, the second challenge is something, a
healthcare provider typically does not need to focus on,
but is forced anyway.
It was this inspiration that led Med A-Z come up with a
solution that allows healthcare providers to concentrate
on patient care. The company will take care of the rest,
including claims and reimbursement, regulatory issues,
guidelines etc.
Evolving with Hindrances
Med A-Z was started in 2003. In more than a decade, the
company evolved from challenges with mitigating
strategies employed.
Initially, educating clinicians on ROI as compared to
devices like EKG machines was a challenge. To resolve
this, the company started offering the E.H.R as a point of
care tool to its customers to help reduce liability and
increase revenues. After that, proving that the tool did
not slow down its customers’ patient flow became the
obstruction for the company. Thus, its internal clinical
experts benchmarked the amount of time taken which
was 6 minutes. They had to go back to the drawing board
till they were able to simulate a flow that was
comparable to the amount of time clinicians took to
transcribe or handwrite notes.
Later on aroused the bandwidth issues, due to telephone
modem based ambulatory environments. Thus, Med A-Z
built high speed bandwidth into its offerings.
Additionally, the company also built HL7 interfaces with
different diagnostic modalities like X-Ray, Nuclear
Echos, EKG machines, etc. to ensure that the work was
not duplicated while entering clinical or diagnostic test
orders. The company also dealt with the obstruction of
fluid change in technology for prevention of data loss
that mandates technical expertise at practices by its Skin-
in-the-game approach.
It’s more than a Database
Med A-Z is not merely a or a thatdatabase system
integrates billing, patient demographics or standard

based patient disease information. Its solutions are an
eco-system.
The development team at Med A-Z constantly monitors
changes in the industry to keep its clients and itself up-
to-date with clinical, regulatory and reimbursement
changes. Issues brought to its year-round are addressed
by its 24-hour support specialists. Through this, it
ensures the continued enhancement of a unique fully
integrated platform, which it is able to offer at
accommodating pricings as practices and the industry
continue to grow. Med A-Z was the first in the industry
to offer Electronic Health Records free of charge as part
of its billing services for clients.
The main strategy of Med A-Z was to create an
interactive vision that’s about more than technology. It
did this by encompassing the solutions around the
policies, practices and continuously evolving processes
of the health care industry. This allows its clients to
seamlessly adapt to the changes mandated by regulatory
controls and policies by reconciling information into a
single customer resource that serves their changing
needs.
Addressing Industrial Challenges with its Unique
Qualities
Med A-Z believes in serving below qualities with its
offerings:
Interoperability - With paper based records phasing out
of the medical industry, data technology is becoming
increasingly powerful and comprehensive. Patient
medical records are now accessible than ever before and
information exchange is beginning to occur in real time.
However the challenges around interoperability between
various healthcare systems remain. Med A-Z and
®
MAI EDEN have been built with interoperability in
mind. Data sets are kept isolated in separate containers to
share with other systems and data exchange layers have
been built for ease of interfacing with third party
systems.
Value based care - There is a notable change in health
care industry, where a move from ‘volume-based-
reimbursement’ to ‘value-based-reimbursement’ is
happening. Focus is shifting toward value based care
model from traditional fee-for-service model. Med A-Z’s
®
analytics product MAI EDEN helps in outcome based
treatment for patients. It also helps to analyze different
parts of an electronic chart so that the right information
is presented.
Data Security - As more and more medical data gets
digitized and transmitted electronically, the company end
with vast amounts of EHR data. Keeping these data safe
and secure is one of its primary areas of focus.
New Revenue Streams - New trend, which is emerging, is
the quest for hospitals to identify new revenue streams,
not just managing revenue cycles but creating new ones.
Med A-Z works with several customers implementing
new revenue streams.
Futuristic Strides
Med A-Z is focusing on mobile enabled versions in
North America and rolling out its Med A-Z Complete
®
and MAI EDEN solutions to customers in EMEA,
APAC regions in the near future. The company is also
focusing on the simplicity and mobility of its EHR
®
solution. MAI EDEN is constantly being updated with
improved risk adjustment modeling and analytics, and
continuing to adopt best practices in the healthcare
industry.
Med A-Z has been working on a continuing education
tool for doctors in developing economies, emphasizing
on right mix of preventive and curative care. It is also
looking to integrate its solutions with solutions from
other companies that are complementary to its offerings.
It’s not merely a
database or a system
that integrates billing,
patient demographics or
standard based patient
disease information. It’s
an environment.

®
UNITEDHEALTH GROUP
What Health Care
Can Do When It’s
Caring and Smart
www.unitedhealthgroup.com

Address :
Country :City : State : Zip :
Global Subscription
Date :Name :
Telephone :
Email :
1 Year ......... $250.00(12 Issues) .... 6 Months ..... (06 Issues) ..... $130.00
3 Months ... (03 Issues) .... $70.00 1 Month ...... (01 Issue) ..... $25.00
READ
IT
FIRST
Never Miss an Issue
Yes, I would like to subscribe to Insights Success Magazine.
SUBSCRIBE
T O D A Y
Check should be drawn in favor of: INSIGHTS SUCCESS MEDIA TECH LLC
Insights Success Media Tech LLC
555 Metro Place North, Suite 100,
Dublin, OH 43017, United States
Phone: (614)-602-1754,(302)-319-9947
Email: info@insightssuccess.com
For Subscription: www.insightssuccess.com
CORPORATE OFFICE

Management BriefCompany Name
Abionic SA
abionic.com
Dr. Nicolas Durand
Founder & CEO
Abionic SA is a Swiss medtech company headquartered
in Lausanne that specializes in medical devices and in
vitro diagnostics.
AdhereTech
adheretech.com
Josh Stein
Co-founder & CEO
AdhereTech’s program increases adherence to specialty
medications by approximately 20%
ALLSCRIPTS
allscripts.com
Paul Black
CEO & Board Member
Allscripts is leading the healthcare IT movement into the value-
enabled world of tomorrow.
Ceresoft
ceresoft.com
Dr. Hsing-Hen Chen
President & CEO
CereSoft, Inc. provides application service provider based data
capture solutions for the healthcare industry.
MedA-Z develops and markets information technology
solutions to the healthcare industry.
NextShift is a healthcare technology innovation company
committed to better healthcare by working with its clients and
partners to develop breakthrough digital solutions.
Rethink is a global health technology company providing cloud-
based treatment tools, training and clinical supports for
individuals with developmental disabilities and their caregivers.
Self Care Catalysts Inc. develops healthcare technology solutions
for patients.
Vee Technologies is a global business process management
ﬁrm. The company provides strategic services to leading global
businesses that help them reach their full potential.
eData Platform
edataplatform.com
Nathan Rozenfeld
CTO & Founder
eData Platform is an innovative technologically advanced
platform that enables an organization to deploy a suite of
tailored business applications.
MedA-Z
medaz.net
Satish Kumar
CEO
NextShift
nextshift.com
Imran Deshmukh
CTO
Josh Caggulia
CMO
Rob Tedesco
CEO
Rethink
rethinkﬁrst.com
Daniel A. Etra
Co-founder & CEO
Self Care Catalysts
selfcarecatalysts.com
Jared Adams
CMO
Vee Technologies
veetechnologies.com
Chocko Valliappa
CEO &
Managing Director
The
Most Innovative
HEALTHCARE

Building Open
and Connected
Communities
of Health
Allscripts:
Allscripts is a leader in healthcare information
technology with a 30-year history of excellence.
The company has a vision to build open and
connected communities of health that advance clinical,
financial and operational results.
Its innovative solutions connect people, places and data
across its vision of an Open, Connected Community of
Health™. This connectivity empowers caregivers to
make better decisions and deliver better care for
healthier populations.
Allscripts creates tools that address virtually every aspect
of population health, an each of these tools facilitates
real-time analysis and action. They enable healthcare
organizations to analyze and act – right at the point of
care – to empower change, improve health, and reduce
costs.
CareInMotion™ is the company’s comprehensive
population health platform. It brings together care
coordination, patient engagement, connectivity, data
aggregation, and analytics at the point of care.
A Veteran Leader
Paul Black currently serves as a Board Member and
the CEO of Allscripts. Paul leads the company in its
commitment to build open, connected communities of
health.
Prior to joining Allscripts in 2012, Paul spent more than
13 years with Cerner Corporation in various executive
positions and retired as its CEO in 2007. During his
tenure, he helped build the company into a market leader
in healthcare information technology with more than
$1.5 billion in annual revenue.
Paul also spent 12 years with IBM Corporation in a
variety of leadership positions in sales, product
marketing, and professional services. He has served on
the boards of several private companies and nonprofit
organizations involved in healthcare information
technology, healthcare services, and consumer Internet
marketing.
He is currently the immediate past chairman and an
officer of Truman Medical Centers, a 400-bed safety net
academic hospital in Kansas City, MO. Paul holds a
CEO & Board Member
Paul Black
August 2018|18

community through open and interoperable solutions
that empower communication, collaboration, and
coordination for better outcomes.
Ÿ Innovating to improve the practice of medicine and
the process of care delivery.
Superior Patient Engagement
Allscripts believes that healthcare doesn’t begin and end
with just providers and patients, and it is the only
company that brings all healthcare stakeholders together.
By collaborating with payers, health plans and programs,
pharmaceutical and life sciences companies, and
employers, Allscripts has gained a wider view of the care
process. It uses that perspective to create innovative tools
that lower costs and improve care.
Allscripts offers the industry’s only vendor-agnostic
patient engagement platform. With the advantage of
open access across the care community, providers can
communicate effectively and engage patients directly,
creating game-changing improvements in patient
outcomes and operational performance.
Allscripts believes that the patient is at the center of
everything it does. Modern healthcare consumers
understand the benefits of engagement, and they expect
to be active participants in their own care. The
organization partners with providers to deliver an
improved patient experience where individuals have a
greater say in the treatment they receive.
With Allscripts, healthcare organizations have at their
disposal the critical tools required for ongoing
communication, effective education, and regular
interaction with patients. These tools make it easy for
caregivers to engage and quickly respond to consumers
while also offering them full, immediate access to their
healthcare information.
Evolving and Overcoming Challenges
When Allscripts was founded in 1986, its primary
business was repackaging medication for point-of-care
distribution. In the 1990s, Allscripts started transforming
the doctor’s office with comprehensive practice
management and electronic health record (EHR)
solutions.
Bachelor of Science degree from Iowa State University
and a Master of Business Administration degree from the
University of Iowa.
Committed to Client Success
Allscripts is the original open, connected health
platform. Thousands of the top hospitals, health systems,
physician’s practices, and healthcare facilities use the
company’s EHR, financial management, and population
health management solutions.
As a true healthcare IT innovator, Allscripts introduced
the concept of an open platform connecting all points of
the care community over a decade ago in 2007. The
organization provides advanced, reliable, client-focused
solutions that enable smarter care to be delivered with
greater precision. This makes for healthier patients,
populations, and communities.
The organization contributes to its clients’ success by:
Ÿ Strengthening their IT foundation through the most
comprehensive and user-friendly clinical and
financial solutions available today.
Ÿ Providing insights and innovations so they can meet
the operational, regulatory and quality demands of
today’s - and tomorrow’s - healthcare environment.
Ÿ Connecting everyone across the healthcare
We are a team of more
than 7,000 devoted to
fulfilling your needs
today and creating the
healthcare IT architecture
of tomorrow.
“ “
|August 2018 19

To address fragmented care delivery, Allscripts merged
with acute-solution leader, Eclipsys in 2010. In 2013,
Allscripts took several significant steps to solidify and
advance its population health management solutions.
This included the acquisition of dbMotion, a leading
supplier of community health solutions, and of Jardogs,
the developer of FollowMyHealth, a patient engagement
solutions provider.
Looking to the future of healthcare, Allscripts launched a
wholly-owned subsidiary, 2bPrecise, a genomic and
precision medicine platform, in 2016. In October 2017,
the company acquired Enterprise Information Solutions
(EIS), the McKesson Corporation’s hospital and health
system IT arm.
This transaction significantly expanded their client base
in U.S. hospitals and health systems, and diversified its
solutions portfolio.
Today, Allscripts is a team of more than 7,000 devoted to
fulling the needs of providers today and creating the
health IT architecture of tomorrow.
The healthcare IT industry is extremely competitive and
Allscripts distinguishes itself by creating tools that
facilitate real-time analysis and action. Its solutions
enable healthcare organizations to analyze and act – right
at the point of care – to empower change, improve
health, and reduce costs.
In addition, the company addresses virtually every aspect
of population health. Allscripts provides a
comprehensive population health platform, brings
together care coordination, and promotes patient
engagement, connectivity, data aggregation, and
analytics at the point of care.
The Future Roadmap
Allscripts acknowledges that it is becoming increasingly
difficult to retrofit EHRs to take full advantage of new
innovations such as the Cloud, artificial intelligence, and
mobility. The organization believes that machine
learning will be a critical element in the evolution of
EHRs.
Allscripts built its latest EHR from the ground-up using
human-centered design. This platform is set to transform
the way physicians experience and interact with
technology, as well as improve provider wellness.
Machine learning capabilities incorporated into the
system identify client treatment patterns. It can pre-
populate information based on these patterns and deliver
preference reminders. By constantly tracking user,
organization, and region trends, it creates opportunities
for more efficiency.
The power of artificial intelligence reveals information
relevant to a patient-provider encounter in real time, and
this helps improve the quality and speed of interaction
with the patient. Ultimately, this reduces the amount of
time spent on documentation, helping address the
problems of “EHR fatigue” and physician burnout.
Allscripts is incorporating EHR-agnostic, precision
medicine, and genomic capabilities within providers’
workflows. This will help capture and store genomic data
from a range of sources, harmonize clinical knowledge
and genomic research to identify relevant information,
and then push the resulting insights to the point of care to
better determine the most effective regimen for the
patient.
Allscripts tools facilitate
real-time analysis and
action. Our solutions
enable healthcare
organizations to analyze
and act – right at the
point of care – to
empower change,
improve health,
and reduce costs.
““
August 2018|20

BUILT BY AGENTS,
FOR AGENTS
Today, more than 139,000 associates and over 790 market centers across the
globe are afﬁliated with Keller Williams. And, we want you to be part of the family!
www.kw.com

In 2009, more than 100 million Europeans suffered
from allergies. Ironically, the sharp rise in allergy-
related conditions of recent decades can be traced
back to improved hygiene. European public health
systems have identified this surge as one of the main
factors that put pressure on their infrastructure.
In the biomedical field, the demand for reliable, fast, and
inexpensive products to diagnose allergies continued to
grow. With this finding, Dr. Nicolas Durand and Dr.
Iwan Märki launched Abionic.
They developed an advanced diagnostic platform that
can quickly obtain a patient’s personalized allergy
profile. This in vitro test, which has been designed to be
simple, reliable and cost-efficient, is an alternative to
expensive blood tests performed in laboratories that are
currently used to identify allergies.
Since its establishment, Abionic has used these highly
advanced technologies with a vision to improve
healthcare and enhance the wellbeing of the patient.
Committed to Medical Innovation
In Vitro Diagnostics (IVDs) are medical devices and
accessories used to perform tests on samples, e.g., blood,
urine and tissue that have been taken from the human
body, to detect infections, diagnose medical conditions,
and prevent diseases.
Abionic is committed to revolutionize the world of in
vitro diagnostics with rapid universal point-of-care
solutions. It develops and produces tests that have
proven to be game-changers in each of their respective
markets. Furthermore, they allow access to lab-quality
blood analysis even where there is limited infrastructure
in place.
Abionic utilizes the most advanced technology to supply
healthcare professionals with a novel diagnostic tool. Its
products, the abioSCOPE (the reader), abioGUIDE (the
application for smartphones and tablets), and the tests
containing nanofluidic sensors have been developed and
are assembled by the company in Switzerland.
A Dynamic Young Leader
In 2010, Nicolas Durand, Founder and CEO of Abionic
was fresh out of EPFL with a Ph.D. in nanotechnology
when he launched Abionic in collaboration with Iwan
Märki. The firm was set up to build on Durand’s doctoral
Abionic SA
Revolutionizing the
World of In Vitro
Diagnostics
Dr. Nicolas Durand
Founder & CEO
August 2018|22
The
Most Innovative
HEALTHCARE

Agency, on top of being an active
infantry officer in the Swiss army.
Rapid and Reliable Point-of-care
Solutions
Abionic takes established and trusted
diagnostic principles to the point of
care so patients can get their results
immediately. Recently, the company
announced the CE marking of the
world’s most rapid test for the early
diagnosis of sepsis and treatment
management.
With an annual death toll of more
than 6,000,000, sepsis kills more
people than breast cancer, prostate
cancer, and AIDS combined. Many
of these deaths could have been
avoided if the condition had been
diagnosed and treated earlier.
Abionic’s PSP test, which is an aid at
diagnosis patients at risk of
developing sepsis in real-time has the
remarkable potential to save millions
of lives.
The Pivotal Movement
Abionic has had its sights set on
international expansion since 2012,
when it obtained ISO 13485
certification, an important mark of
credibility and a requirement to sell
medical devices in the European
Union.
The same year, the firm attracted its
first investors with a Series ‘A’
financing round that brought CHF
3.5 million in cash. Two years later,
the first healthcare professionals –
mainly doctors – contacted the
company to test their technology.
research, which aimed to develop a
nanofluid-based system that could
speed up blood test diagnostics.
Nicolas has also been involved in the
development of resonating
biosensors at Carnegie Mellon
University (USA).
He is the winner of the 2006 Omega
Award as well as more than 20
entrepreneurial awards, including the
2010 Young Entrepreneur Award.
Nicolas has earned a private pilot’s
license and was an astronaut
candidate for the European Space
Abionic had to prove that its
nanotechnology could perform as
promised and did so at the first
clinical trials which followed. That
was closely followed by a Series ‘B’
financing round with Swiss and
European entrepreneurs. By then,
Abionic’s prototype had become a
viable product; in 2016, the firm
began demonstrating commercial
traction by selling its devices to the
market.
Recently, the Series ‘C’ round was
closed to secure financing of clinical
impact studies and the development
of further tests.
Today, the entire production chain is
located in Switzerland and based in
Lausanne. It has the capacity to
produce up to one million test kits
per year.
International Expansion
Abionic envisions revolutionizing the
world of in vitro diagnostics with
rapid universal point-of-care
solutions powered with disruptive
nanotechnology. To demonstrate the
test’s medical and economic impact,
the company currently carries out a
large-scale clinical trial of its sepsis
tests in fourteen sites across Europe.
Abionic aims to expand its business
internationally and is working on the
development of further innovative
and impactful tests.
We use the
most advanced
nanotechnology
to supply
healthcare
professionals
with a novel
diagnostic tool
and, thereby,
bringing the
treatment
closer to
the patient.
|August 2018 23

S
ustenance of life has become a dire necessity in
this era which has witnessed a myriad of lethal
disease and other unpredictable natural instances.
These instances have had adverse effects on the average
mortality rates of numerous nations. Radical innovations
in the field of medicine have aided the global population
in defending against such instances. One such innovation
which has successfully reformed the methods of tracking
patient behavior is the smart pill bottle by AdhereTech.
The New York based healthcare leader delivers highly
effective adherence programs to patients, all powered by
their smart pill bottles. This pill bottle enables patients to
recognize when scheduled doses medications are missed.
Its smart bottle technology measures the internal
contents of the bottle, wirelessly uploads the data to
server, and sends reminders to patients who missed a
dose.
Founded in 2011, AdhereTech has customers across five
continents, a robust IP portfolio, and is actively used by
many of the world’s largest pharmacies, pharmaceutical
companies, and healthcare firms.
Innovative Zenith
AdhereTech’s smart pill bottles are designed to improve
medication adherence. The product was designed by
keeping the target users in mind, as they range in age
from adolescents to patients in their 90s. While
designing these bottles the product architects emphasized
on three guiding design principles
Ÿ The company envisioned developing a device that
connects and starts working the moment it is received
by the patient. Hence, the team used cellular chips in
the bottle therefore zero setup is involved and the
customer can start using the bottles from day one.
Ÿ A team of astute professionals recognized even
patients without a technical knowledge must be able
to seamlessly utilize this bottle. Thus, it designed a
device in the exact same manner as the non-
connected version, which helped its users to operate
the device with ease.
Ÿ AdhereTech also focused on making a device that
lasts for as long as possible without being charged.
Whenever it needs to be charged, it should reach out
to the patients who are using it. Smart pill bottles
have 6+ months of battery life per charge. It is
rechargeable, just like smart phones.
In addition to this, the smart pill bottles have the lightest
touch intervention. There are sensors in the bottle which
provides continuous data to the company, no matter
where the smart pill bottle is located. This help’s
AdhereTech
Assisting Patients to
take Medications
on Time
Josh Stein
Co-founder & CEO
August 2018|24
The
Most Innovative
HEALTHCARE

New York City, including and
FreshDirect.
He has also appeared on the
TEDMED stage in 2013 and 2014 as
a featured speaker.
Inspiration and Foresight
According to a report, close to $300
billion loss is incurred in the US
because patients do not take their
medications on time. Over hundred
thousand patients pass away each
year because of medical non-
adherence. Josh, co-founder and
CEO of AdhereTech identified this
problem and invented a smart pill
bottle focusing on medical
adherence.
Josh mentions, “Healthcare is slow
to adopt technology which can be a
challenge, but it can be overcome if a
firm puts an enormous focus on
clinical data and regulatory
compliance.” Josh believes, in
healthcare, the timelines are long:
developing the product, going
through regulatory approvals,
gathering clinical data and expanding
with commercial partnerships. It is
important to navigate these processes
in a detailed, professional, and
experienced manner for the
sustainable growth.
Accomplishments in the Following
Years
AdhereTech sells its smart pill bottles
in five continents, with the majority
of customers in the United States.
The company produces hardware but
considers itself as a data and
software company because it
believes not all types of non-
adherence are the same. It is aiming
at increasing its reach to millions of
AdhereTech to know if and when the
medicines have been taken by the
patients. Consequently its system
matches a patient’s prescribed
medicines with its actual one. Smart
pill bottles are white in color and
glows blue even when a single dose
is missed. These bottles can also
inform patients the volume of
medicines or the number of
medicines left in the bottle.
A Leader with Vision and Passion
Josh Stein is a visionary CEO and
Co-founder of AdhereTech. While
studying at Wharton, Josh founded
AdhereTech in 2011 along with a
group of passionate healthcare and
technology professionals.
Josh considers himself as a design-
obsessed business guy. He is
passionate about using simple
technology to positively influence
patient behavior. At AdhereTech he
strives to create a cellular technology
to monitor patient adherence in real
time and remind patients to take their
prescribed dosage via automated
phone call or text message. Prior to
founding AdhereTech, Josh worked
for a number of successful startups in
patients around the globe. It has
partnered with top pharmaceutical
companies to provide these smart pill
bottles to patients suffering from
cancer, HIV and hepatitis to name a
few. AdhereTech’s smart pill bottles
have reached thousands of people
and has increased medical adherence
by over 20 percent.
We deliver Highly-
Effective Adherence
Programs, via Wireless
Pill Bottles.
|August 2018 25

he pharmaceutical industry is passing through hopeful and turbulent times at the same time today. On one hand, the
Tindustry is facing rising opposition from customers who wish to pay as a single payer. On the other hand, great
innovations are helping pharmaceutical industry meet new customers to grow revenues. An example of the later
development is the digital mobile technology which helps the industry collect large amount of data to form an unparalleled
understanding of healthcare. Additionally, today the pharmaceutical industry is in a position to make a statement to the larger
public to seal its place as the ideal provider of healthcare in the long run. The Pharmaceutical industry can ﬁnd a harmonious
balance between the turbulence and opportunities to claim the throne of a great healthcare provider with real innovation
today.
Currently, the healthcare industry focuses on R&D which can immediately be turned into products to earn revenues. An
example of this economic development is the large number of medical solutions available which treat common illnesses such
as cold, fever, headache, etc. and are usually available as over the counter medicine for patients. This economic activity is
governed by patients who pay as individuals. This economic model is in line with natural principles that advocate that self-
interest is the motivator of economic activity and competition is the regulator. However, there is a new economic expectation
of patients which could better shape the future. If patients paid as a single payer, the government could invest in more R&D
tax dollars into the future in the form of grants or subsidies. Without the infusion of such investments, real innovation would
be diﬃcult as real innovation requires companies to operate in the area of absolute uncertainty, which can be a nightmare
from the point of view of shareholders.
Untapped Innovative Opportunities
In the pharmaceutical sector, the natural economic forces have not yet found solution to deadly diseases like HIV, multiple
forms of cancers, and several others. The primary reason for true lifesaving innovation being expensive is that true innovation
operates in the territory of absolute uncertainty and hence one cannot set a timeline in principle in order to achieve desired
results. Furthermore, this is also the primary reason why deadly diseases which promise lucrative revenues may never see
real investment by individuals who are governed by self-interest. Individual self-interest leaves breathing space for Individual
desire for happiness and is likely to be susceptible to individual weaknesses. On the other hand, if companies received
funding for innovation through a legitimate public entity like the government, it could invest in innovation for the long term
The Next Frontier
of INNOVATION in the
Pharmaceutical
Industry
August 2018|26

growth of a society. Such collaboration would help the
pharmaceutical industry to find solutions that separate life
and death in a meaningful manner in the society. On the
other hand, the individual companies which find a solution
to grave illnesses can also monetize these innovations.
Some such trending innovations are mentioned below.
Precise Medicine
Today the Pharmaceutical industry faces stiff legal penalties
for overdosing a patient with a particular medicine. The
good news is soon doctors would gain access to genomes
which helps map out the individual medical history. This
makes it possible to deliver a perfect and precise dose of
medicine to a patient. Genome projects are gathering
momentum, largely due to an initiative of the Obama
administration, which gave the grant of $215 million to
Precision Medicine Initiative. Grants like these and
projects like these would make it possible to develop
personalized medical solutions which are near perfect for
all patients.
Data Gathering
It is important for doctors and medical researchers to have
access to real intelligent data in order to make objective
observations and produce insightful innovation. Such data
gathering and generation has become much easier thanks to
mobile apps. Today, several mobile phones include
technologies that can track movement, sense various health
indicators and measure the health of patients and provide
the data to doctors and researchers to better understand their
patients. Such data apps are making it possible to create
gene sequencing and live health monitoring, which could
have only been dreamt about in the past.
Artificial Intelligence (AI)
AI has become the guiding light for many industries. The
Pharmaceutical industry is not an exception to this rule.
Supercomputers and machine learning are making it
possible for researchers to detect patterns in genes, diseases
and respond to them with appropriate solutions at a blazing
quick speed. Many such AI projects are currently helping
the Pharmaceutical industry on the path of innovation. One
prime example of this technology in action is the IBM
Watson which has demonstrated learning capabilities and
absorbs millions of pages of medical literature to make the
industry reach the pinnacle of competitive success.
There are many more innovations which are reshaping the
future of the Pharmaceutical industry. Some of these
include 3D Printing, Nanotechnology, Virtual meetings
between doctors and patients, etc. Innovation is opening up
new doors of opportunities for every industry and
companies which follow the path of innovation will find a
golden arch to build a great future for them. However, it is
important for the industry to secure its long term interest by
positioning itself as the ideal provider of healthcare services
in the short run.
Precise Medicine
Articial Intelligence
Data Gathering
|August 2018 27
Care and Cure

The healthcare sector is in a state of constant flux
and institutions are under tremendous pressure
to deliver high-quality patient results while also
maintaining desired profit margins. They have to balance
these requirements while adhering to a growing array of
regulatory specifications and other dynamic forces. In
this scenario, maintaining financial stability is a
challenging but essential task.
Hospitals and healthcare systems are recognized for
treating patients and saving lives but every healthcare
organization also has an obligation to remain financially
viable. Healthcare revenue cycle management plays a
crucial role here.
Healthcare revenue cycle management is the financial
process that facilities use to control and oversee
administrative and clinical functions connected with
processing claims, cyclic payments, and income
generation. The process includes the identification,
management, and collection of patient service revenue.
CereSoft’s Revenue Cycle Transformation works with
healthcare providers to help them recognize ways to
boost their net income, accelerate cash flow, and
decrease costs by addressing people, process, and
technology components across the revenue cycle
spectrum.
Thought Leadership in Healthcare and Technology
CereSoft is a technology pioneer and forward-thinking
company based in Silver Spring, Maryland. It was
founded in 1994 and today has over 200 employees
worldwide. CereSoft can handle the revenue cycle needs
of both large hospital systems and physician networks.
For over 20 years now, has been creatingthe company
feature-rich, real-time digital exchanges with its clients
in the healthcare industry, while demonstrating thought
leadership in both healthcare and technology services
throughout the United States.
CereSoft’s one-stop solution for healthcare revenue
cycle management is spearheaded by its flagship product
and web portal, MedAR. MedAR allows users to handle
correspondence, financial analysis, denials,
underpayments, refunds, dependent claims,
re-associations, and other critical online functions within
a single system.
MedAR provides complete revenue cycle transformation
for medical practices as well. Its financial management
On-line Navigation System reduces the time required to
process manual posting to billing systems, denial
processing days, manual keying of transactions, and the
time required to balance.
CereSoft:
Energizing Healthcare
Cash Flow
Dr. Hsing-Hen Chen
President & CEO
August 2018|30
The
Most Innovative
HEALTHCARE

A Single View Portal with Touch
and Feel Design
CereSoft is constantly seeking true
partnerships. More than 80% of its
portal is connected with its users, and
the touch-and-feel architecture of the
platform is a result of their valuable
feedback.
Clients expect a ‘Single View’
platform that can handle both paper
and electronic formats, as well as
structured and un-structured data in a
single application. CereSoft offers a
true virtual work desk where every
employee has access to a Single
View of all financial transactions.
The integration of all fragmented
components and document types in
one platform allows clients to search,
retrieve and view all data and file
sources on a single system. This
leads to performance characterized
by high speed, accuracy, reliability
and efficiency.
CereSoft has the finest sales and
marketing organization in the country
that are not sales-based people; they
are consultants that provide problem
solving techniques to all their
customers and business partners.
Visionary Leadership in an
Evolving Industry
Dr. Hsing-Hen Chen is President,
Founder and CEO of CereSoft.
Dr. Chen has an unusual background
for this industry. He has been a full-
time professor in Physics at the
University of Maryland for the past
40 years, and started off as an expert
in non-linear complex systems that
include neural networks, and deep
learning AI systems in particular.
This unique background led him into
It also allows the provider to view
any electronic document with a
single touch. CereSoft’s great
references, functionality, and ability
to complete the paper conversion to
EDI processing in less than 24 hours
helps clients improve their revenue
management and move forward on
their innovative journey with notable
speed.
CereSoft provides claims
presentment to the payer gateway
and accepts both ERAs and Paper
EOBs for processing. The company
matches and balances that
information with ACH/EFT
payments and paper checks.
CereSoft’s online portal processes
both co-pays and patient pays as they
are integrated into the CereSoft
Desktop Navigation System.
The company provides a
SingleTOUCH Methodology under a
SingleVIEW.
the business document and process
renovation field. Dr. Chen envisioned
automating the healthcare RCM
process to integrate claim
submissions, payment adjustments,
cash posting and other necessary
business workflows.
He developed an intelligent process
to capture business data from
structured, semi-structured and even
fully un-structured documents,
including databases, electronic files,
business forms and paper
correspondence.
Dr. Chen’s visionary leadership has
positioned CereSoft as the company
to watch in this fast-evolving
industry.
Cutting-Edge Technology and
Innovation
The CereSoft system is field-proven
across both large- and small-scale
implementations and it has shown
that it is capable of meeting special
requirements and adapting to
customized business rules.
CereSoft is committed to integrating
leading edge technology and
innovative payment methods into its
flagship Payment Central Platform,
which includes features like checks,
mobile pay with image recognition
technology, document understanding
and artificial intelligence.
The company envisions employing
robotic process tools and block chain
technology to enhance the security
and efficiency of its intelligent
system.
Anyone with an
internet connection,
anywhere in the world
can access, monitor
and work using our
cloud-based platform.
This will provide
significant cost
reductions in the years
to come.
|August 2018 31

For all the technological advances of recent times that
continue to transform the way we live, work and
interact, huge gaps in the quality and delivery of
healthcare remain a dismal reality. Not only do these
shortcomings endanger lives and affect patient wellbeing,
they also have a negative impact on the investments of
stakeholders in the healthcare industry.
The ability to leverage technology and bridge the
information gap has the power to revolutionize healthcare
today and mold its future tomorrow. A Florida-based
company is surging forward with that goal as its
mission statement.
Meet eData Platform.
Fomenting Meaningful Change
eData Platform is, at its core, a software development
company. However, that is a very superficial description for
an organization that is truly on the cusp of bringing real,
meaningful, and lasting change to healthcare.
eData Platform is not just developing software in the way
that countless other companies do. Instead, it has already
succeeded in creating and implementing a cloud-based
enterprise data management platform that utilizes cutting-
edge technology to achieve medical record management
interoperability.
The company has timed its development perfectly - the
network of interconnected devices that constitutes the
Internet of Things (IoT) is adding an entirely new
dimension to the equation in their favor.
Incorporated into the platform, it reinforces and magnifies
their ability to gather, collate, organize and employ critical
and peripheral data in real time. eData Platform calls the
concept ‘Real Time Interoperability’.
Both patients and healthcare professionals get
unprecedented control and access to medical data at any
place and at any time with this groundbreaking approach.
Patients before Profit
The company has used an agnostic foundation for its
platform. This simplifies development and expansion while
allowing users to seamlessly adopt new technology and
avoid costly upgrades.
The concept remains the same, regardless of the specific
vertical that the client is deploying, be it DMR, a Case
Management System, or LIMS (Laboratory Information
Management System). eData Platform installs on top of
their core structure so access to tools and other utilities is
upgraded, not lost.
Critically, maintenance requirements are drastically reduced
and clients get an improvement in capabilities without the
accompanying expenses.
This was a very deliberate business decision taken by the
eData Platform team. They are averse to what is known in
eData Platform:
The Future of
Healthcare Software
August 2018|32
Nathan Rozenfeld
CTO & Founder
The
Most Innovative
HEALTHCARE

personally involved in more than 250
software solution implementations
worldwide. The breadth of expertise
and depth of firsthand knowledge
garnered across his brilliant career is
now driving eData Platform’s
trailblazing march into the future.
“I have been fortunate enough to work
on a very diverse range of projects and
with such varied clients,” he says.
“That has given me a sixth sense for
what will work and what won’t in a
healthcare data management solution.
What we should take into
consideration when we design a system
and what we should avoid, who should
be our audience and who should be the
driving force.”
“All these things, combined together
with my experience and feel give me
the confidence to lead a very talented
and skilled core team of designers.”
A Pressing Need
Nathan says that two primary factors
drove eData Platform’s entry into the
healthcare arena.
“Globalization and rapid development.
Many parents are concerned about the
shift from disease prevention to disease
management that they have seen since
their own childhoods. Medication is
pushed on children unnecessarily and
while we enjoy greater life
expectancies, it is driven by pills and
procedures.”
eData Platform wants to use data to
circumvent the treatment phase. It is
using advanced analytics to predict
potential problems and prevent them
before they occur. The company
envisions this early response system
replacing the current healthcare
approach that it believes is
disproportionately reliant on passive
intervention.
the industry as a ‘vendor hostage’
situation where the client has no choice
but to persist with expensive upgrades
because changing vendors is both
financially and practically unfeasible.
By contrast, eData Platform is very
transparent with its systems and
refrains from imposing long-term
contracts on clients. They have the
choice to leave at any time after the
initial period of agreement and take all
their data with them.
Experience-Driven Leadership
Insight Success spoke to the Chief
Technology Officer of eData Platform,
Nathan Rozenfeld, who also performs
the role of senior solutions architect
with the company’s core R&D team.
Nathan has been in the industry for
over two decades and has been
As an example, Nathan quotes the
statistics of the effectiveness of the flu
vaccine during the most recent
flu season.
“The inefficiency was 37%,” he
exclaims, “Can you imagine the
mortality that it would have caused?
With the correct and more complete
information available to doctors in real
time, they could have gauged the
situation and made better-informed
decisions that would have saved lives.”
Standing Distinctly Apart
eData Platform recognizes that
software systems have often been
regarded as a necessary evil by most
healthcare industry professionals. They
tend to believe that the technology
makes life easier but is expensive and
difficult to maintain while changing
systems is extremely disruptive and
requires tedious retraining.
A holistic, open software system is the
eData Platform difference.
“AI and predictive engines are our
proactive healthcare partners,” explains
Nathan, “Dynamic data goes so far
beyond what the current EMR and
EHR systems offer that it is like
equating a space shuttle to a horse
carriage – there is simply no
comparison!”
eData Platform wants to give
healthcare professionals the resources
and the technology that will enable
them to spend less time with software
and more time with their patients who
need them.
Our business is
built on using
our product to
help our clients
solve their
information and
operational
challenges.
|August 2018 33

Why Supermarkets
Need To Talk To
Millennials In
Their Language
The word millennial has been
thrown around carelessly for
a while now but only a few
have understood the signiﬁcance of
what this means. They are not the
loud and self-absorbed demographic
that the media has made them to be,
but rather a highly intelligent, well-
educated, multitasking generation
with a spending power of close to
$3.39 Trillion in 2018, according to
Oracle.
So who are they, and why do they
matter? Millennials are those born
between 1977 and 2000. 1 in 4
millennials are parents today, and are
2.5 times more likely to adopt a new
technology compared to their older
counterparts. Millennials are a
generation of smartphone wielders,
and the growth on the reliance of
mobile applications that save time is
on the rise. According to Edelman
Digital, 42% of millennials have
already made purchases using their
smartphones.
How you communicate is as
important as what you
communicate
A conversational tonality that is
accessible and human is what
connects the millennials to a shop
and brand. By taking a more personal
approach ad campaigns, customers
can feel more valued. Rather than
just talking to the masses, brands that
have started using social media
networking pages to advertise their
products are able to communicate
directly with individuals.
Intelligently persuasive content will
inevitably attract an audience. It’s
this type of audience that will also be
interested in future content pieces
and accept the brand as a trusted and
informative source of wanted
information. This long term
relationship can then be dotted with
compelling reasons to purchase and
convert readers to buyers.
InstaShop is the easiest
way to order groceries
and have them delivered
to the customer’s
doorstep in less than 30
or 60 minutes average
time depending on the
location. The organization
oﬀers a convenient and
seamless grocery
shopping experience that
frees its clients from the
unavoidable chore of
heading to the
supermarket with all the
challenges they may face
there. The result?
Customers get much
more time to enjoy doing
the things they love the
most with the people they
love the most!
About the Company
August 2018|34

Mobile grocery shopping is now the next big trend
A 30-year old working mother comes home to a crying
baby, and remembers that she needs to purchase milk.
She quickly whips out her phone and places an order
from the nearest online grocery shop without the hassle
of calling, communication mishaps, and cash
withdrawals.
To connect with this rising smart demographic, brick and
mortar supermarkets cannot simply rely on traditional
industry techniques that were prevalent in the 1990s and
the 2000s. In that period, marketing was done through
conventional techniques of leaﬂet distributions, and
general word of mouth. But this has shifted slowly but
surely. A reputation of a brand or a supermarket may in
fact be dictated solely based on whether they have an
online presence or not. A trending on-demand app
culture has been taking over the millennial generation. In
2015, online grocery sales in US alone amounted to $7
billion, and is expected to rise to $18 billion by 2020.
Convenience and reliability is the critical factor that
keeps this generation loyal. InstaShop, a UAE based
online grocery delivery app backed by Souq.com, Jabbar
Internet Group, and Venture Friends who partner with
local supermarkets and brands, noticed that those who
have downloaded the apps order at least once per week.
Limited push notiﬁcations on phones with regular
discounts has been quite successful in increasing grocery
purchase. However, too much of that, and the user may
uninstall the app.
At the end, brick-and-mortar groceries and supermarkets
need to build a new content strategy and partner with
online delivery shopping applications that will help to
transition to this new era of digital delivery options to
ensure existing demographics are not missed out on.
John Tsioris is the Founder and
CEO of InstaShop, the leading on
demand grocery shopping app
in the GCC, operating in the
region since 2015 and having
been nominated for two
consecutive years as one of the
most promising startups in the
Arab world by Forbes. InstaShop
is present in 4 countries
& expanding.
The platform allows users to
access their nearby supermarket
directly through their mobile app
and shop for groceries with
delivery straight to their door in
30 to 60 minutes depending on
location. in 2016, Souq.com
invested In Instashop.
About the Author
John Tsioris
Founder & CEO
|August 2018 35
Director’s Viewpoint

NextShift is a healthcare technology innovation
company committed to better healthcare
through revolutionary digital solutions
developed with its clients and partners. NextShift’s
comprehensive offerings are designed to simplify
engagement and delivery for health services. From
mobile apps to cloud operations and platform-based
solutions, and from artificial intelligence and IoT, the
company is creating and transforming the healthcare
technology of the future.
The company’s vision can be best summarized by the
mantras to which it holds itself ’Creating Better
Healthcare™’ and ‘What’s Next?™’. These two phrases
drive its continued commitment to innovation. The
organization believes that patients can be the best
caregivers, and that one’s health should be directly
integrated into their everyday lives.
Big Picture Leaders
NextShift benefits from having three forward-thinking,
solution-driven personalities that offer unique
perspectives in their individual areas of expertise. Rob
Tedesco is the CEO while Imran Deshmukh and Josh
Caggiula are the CTO and CMO respectively.
They formed a partnership after agreeing on a unified
goal to craft innovative healthcare solutions through
cutting-edge technology. The diversity of their
experiences allows for unique and differentiated
customer care and a work environment that empathizes
with its employees while encouraging them to strive to
deliver optimal solutions.
The NextShift leadership team comprises vast
experience having supported over 300 digital solutions
and a solid understanding of the importance of HIPAA
compliance and quality practices governed by ISO 9000.
With extensive technical experience, it allows NextShift
to design and develop enterprise web and mobile
solutions, such as highly integrated Connected Health
Platforms. This has afforded NextShift to work with
leading health organizations including Johnson &
Johnson, Aetna, Gore Medical, Mount Sinai, Janssen
NextShift:Creating Better Healthcare
Rob Tedesco
CEO
Josh Caggulia
CMO
Imran Deshmukh
CTO
August 2018|36
The
Most Innovative
HEALTHCARE

At NextShift the focus is on all of the
stakeholders within healthcare. This
includes patients, pharma, insurance
companies, pharmacies, providers,
the government, and other
stakeholders. The opportunity is to
have these type of organization work
closer together in a more integrated
way in order to create high-impact
solutions that are both simple to use
and compliant.
The diverse team of experienced
strategists and technology experts at
NextShift partners with clients across
the healthcare landscape, and this
gives them a unique bird’s eye view
of where common areas for
improvement are needed. The
company delivers solutions and
services aligned with their client’s
needs while driving innovation and
transformation across the health
landscape using proven and new
technologies.
NextShift stands out because it
believes the technology it creates
should enhance people’s lives, not
complicate them. The organization
strives towards making health
information easy to access and
understand, as well as interactive and
intuitive. The simplicity of the
solutions NextShift develops is
always at the forefront of its strategy.
Embracing What’s Next
NextShift sees enormous
opportunities to both simplify and
evolve existing health systems while
also creating new ones to empower
healthcare providers and patients. As
devices are becoming more health-
centric, there has been an explosion
in the popularity of wearables.
Healthcare Innovation, Lymphoma
Research Foundation, Cancer Care,
and others.
Transforming Health
NextShift believes that the healthcare
industry is fragmented, expensive,
and complex for patients to navigate.
While most other industries have
beneﬁted from advancements in
consumer technology, healthcare is
still several years behind. The
complexity of securing patient data
and lack of interoperability across
health systems and platforms are the
main reasons for this.
NextShift sees incredible potential by
embracing and enabling integration
across the Internet-of-Things and
leveraging vast data sources to foster
a smart foundation for artiﬁcial
intelligence (AI) solutions.
Blazing the Path Forward
NextShift has grown organically over
the past 4 years based on its strong
focus on people, process, and
technology. The company has built a
team of ambitious technologists,
designers, developers, data scientists,
and strategists who align with
NextShift’s culture and mission.
With close to 30 employees globally,
the organization’s continued growth
has been driven primarily by close
relationships with its clients to
become their go-to partner for
technical solutions and services.
By securing Fortune 500 clients early
in their journey, they have grown
steadily while continuing to provide
exceptional quality and service.
As a highly innovative company,
NextShift plans to propel its
CareWare™ pipeline of products as
“software as a service” solutions and
continue to expand its services in
DevOps and Cloud Automation.
Our talented team
comprises
industry experts
across healthcare,
marketing, and
technology that
create custom
solutions to meet
our clients’
strategic
requirements.
|August 2018 37

Biotechnology is a the exploration and development of various biological
processes to achieve mainly industrial and various other purposes
cultivation of the plants, and improvements through breeding programs.
The processes also employs artificial selection and hybridization which emphases
its functionality. At present, the modern usage also includes genetic engineering as
well as cell and tissue culture technologies.
In earlier days biotechnology process was initiated by farmers who developed
improved species of plants and animals by cross-fertilizing or cross-breeding. In recent
years, biotechnology has expanded its core functionality widely which now focuses on
sophistication, scope, and applicability.
A well-known and author and writer is vague and can be unsubstantial, for example,
Clayton Christensen share his views as, “There are other dimensions of biotechnology. If
you think of biotechnology like the Internet, it’s not a category - it’s an infrastructure that
can be deployed to sustain or disrupt. In healthcare, the most complex problems at the high
end have to be dealt with in a problem-solving mode by the best, most experienced
physicians you can find.”
Biotechnology is immensely contributing towards agriculture which enhances its
functionality to the next level. Agriculture aspects have extremely changed with
biotechnology functions and increase readability of the process.
What is Agriculture Biotechnology?
Agricultural Biotechnology is also known as Agritech. It is an area of agricultural
science involving the use of scientific tools and techniques. There are several
techniques used in agriculture biotechnology such as Genetic Engineering,
Revolutionizing Agriculture Process Globally
Agriculture
Biotechnology:
Agriculture
Biotechnology:
August 2018|38

Protoplast Fusion: Protoplast fusion is
also known as Somatic fusion. It is a
type of genetic modification in plants by
which two distinct species of plants.
In this method, it includes joining
of cells or cell components to
transfer traits between species.
Transgenics: Transgenics is the method
which involves the insertion of one piece
of DNA into another organism’s DNA. It
works in order to introduce a new gene
into the original organism. This addition of
genes into an organism’s genetic material
creates a new variety with desired
qualities.
Impact of Agriculture Biotechnology on
Economy and Social Life
The technology used in agricultural
productivity improved its usability and
functionality with some major factors
such as combine harvesters,
chemical fertilizers, and the green
revolution. Like every technology,
agricultural biotechnology will
also have its major impact on
economic and social.
In agriculture, crops using biotechnologies
have improved its quality and also been
used safely with benefits. The technology
influences the whole process by the
reduction of pesticide use. At present
agricultural biotechnology, one of the
factors that influence the health and
welfare of the farmers and other citizens in
the developing world.
Influence of Agriculture Biotechnology
in the Future
The aim of agricultural biotechnology
is to present the functionality of the
applications used in agriculture
biotechnology. The applications
are eagerly awaited to increase
Molecular Markers, Molecular Diagnostics, Vaccines,
and tissue culture. And it also modifies the living
organisms like Plants, Animals, and Microorganisms.
In recent times, Crop biotechnology has been developed
its functionality in agriculture and is also one of the main
aspects of agriculture biotechnology. Its desired qualities
are exported from a particular species of Crop to an
entirely different species.
How is Agriculture Biotechnology Used?
Genetic Engineering: The term is derived from
scientific research provides information about how to
move genes from one organism to another. This is known
as genetic engineering (GE) or genetic modification
(GM). Genetic engineering includes the transfer of
useful characteristics by inserting DNA of Plants, animal
or microorganism from another organism to another.
Molecular Diagnostics: Molecular diagnostics
significantly detect genes or gene products that are very
precise and specific. Molecular diagnostics is the method
used in agriculture to more accurately diagnose
crop/livestock diseases.
Tissue Culture: Tissue culture is the process of
regeneration of plants from the disease-free plant. This
technique allows reproduction of disease-free planting
material for crops.
Unified Methods Used for Corp Modification
Traditional Breeding: Traditional breeding method has
been used for centuries to improve crop quality and
quantity. The crossbreeding describes the combination of
two compatible species to create a new variety with the
desired traits. The crossbreeding can be only utilized
within the same or closely related species.
Polyploidy: Polyploidy is the method describes which
can be induced to modify the number of chromosomes in
a crop in order to influence its fertility or size. Through
naturally or with the use of chemicals, the number of
chromosomes can change. The process results in the
fertility changes in modification within the crop.
|August 2018 39
Agri Tech

the productivity of crops, primarily by reducing the costs
of production by decreasing the needs for inputs of
pesticides. The process is mostly used in crops grown in
temperate zones. The application of agricultural
biotechnology can improve the quality of life by
developing new strains of plants that give higher crops.
The crops can be grown in a wider range of
environments which give better rotations to conserve
natural resources. It also provides more nutritious
harvested products that keep much longer in storage and
transport, and continue low-cost food supplies to
consumers.
According to Crop Science, the company with credible
authority on the progress and future implications of
Agricultural biotechnology states that, “Farming is
evolving in the 21st century with the development and
use of biotechnology crops. Scientists and agronomists
work in the lab and greenhouse to come up with genes
that improve crop yield and make corn, soybean, cotton
and canola plants more resistant to insects and more
tolerant to herbicides, drought, and stress.”
The biotechnology and its process is the evidence of the
contributions towards rural development around the
world. It serves as the source of inspiration for emerging
nations to complement existing practices with
agricultural biotechnology.
August 2018|40

“Next gen Travel Concierge”
www.fareportal.com

According to the Centers for Disease Control
(CDC), 1 in 6 children will be diagnosed with a
developmental disability such as autism. This
makes the condition more common than pediatric cancer,
diabetes and AIDS combined. Applied Behavior Analysis
(ABA) is the main treatment methodology recommended
by the American Academy of Pediatrics, the U.S. Surgeon
General and the U.S. National Institute of Mental Health for
treating individuals with developmental disabilities.
However, the highly limited availability of credentialed
ABA providers – there are approximately only 25,000
Board Certified Behavior Therapists worldwide - severely
restricts potential benefits for the hundreds of millions of
affected individuals. Rethink was founded with a mission
to address this challenge.
To effectively and affordably meet the treatment needs of
this growing segment of the population, Rethink determined
the only way to deliver clinical best practice treatment in a
scalable way was to leverage technology to train whoever
was caring for the individual. Noting extensive research on
the effectiveness of video modeling for training in fields
such as medicine and the military, the Company decided to
combine this established method of instruction with the
proven and medically-recommended ABA treatment
methodology. The visionary Company then created an
online training, treatment and support system for patients
and their caregivers.
An Industry-Leading Platform
Through its three divisions, each with distinct versions of
its online program, Rethink is the leading software platform
serving the three key market segments that offer care to
individuals with developmental disabilities:
Ÿ Education – Rethink offers the leading special needs
management platform for public school districts.
Serving all students with special needs as well as those
who require behavioral support, the Rethink program is
used across all 50 states by hundreds of districts ranging
from large urban systems like New York City, San
Francisco, Dallas and Denver to small, rural districts.
The Rethink program allows districts to fully meet
Federal IDEA requirements as well as a variety of state-
based legislative mandates to provide adequate
education to students with special needs.
Rethink:
Empowering Individuals
with Developmental
Disabilities
Mr. Daniel A. Etra
Co-founder & CEO
August 2018|42
The
Most Innovative
HEALTHCARE

specializing in individuals with
autism and related disorders. The
software helps improve treatment
outcomes by simplifying and
automating work flows, improving
staff training, and ensuring
standardization and delivery of
clinical fidelity of care’.
Scalable and Fully Integrated
Solution
Rethink began by offering treatment
tools, training and support for
individuals with autism, who account
for 1 in 68 of the population, as well as
their caregivers. They then leveraged
their clinical expertise and best-in-class
platform to expand beyond autism to
broader developmental disabilities,
including conditions such as
developmental delays, intellectual
disabilities, speech and language
problems, Down Syndrome,
ADD/ADHD and a range of problem
behaviors. This demographic
constitutes 1 in 6 of the population.
One of the biggest challenges early on
was securing the approval of the
clinical/academic community. They
had to convince them that a
technology-driven solution could be
applied by a caregiver to an issue that
historically was addressed with on-site
intervention by a trained and certified
clinician. To address this issue, Rethink
made sure to involve leading clinicians
and academics in the program’s
development , as well as secure the
support of leading advocacy groups
and related not-for-profits,.
Rethink is unique in the marketplace
for offering a scalable and fully
integrated solution to address the needs
of both individuals with a
developmental disability and their
caregivers. Rethink’s employees share
a deep passion for making a social
impact and drive continuous
innovation in its products. The Rethink
Ÿ Employee Benefits – Rethink offers
the industry-leading training and
support platform for employees
caring for dependents with a
developmental disability. Its clients
range from small employers to
those with over 500,000 employees.
Research has shown clearly the
adverse impact of caring for a
dependent with a developmental
disability – from over twice the
rates of anxiety and depression to
thousands of dollars annually in
lost productivity. Indeed, over half
of caregivers work fewer hours or
leave the workforce to
accommodate the needs of their
child. The Rethink program helps
support these employees, directly
impacting their productivity in the
workplace, and helps employers
create a culture of wellness for their
entire workforce.
Ÿ Behavioral Health – Rethink offers
the industry-leading practice
management platform for
behavioral health service providers
program touches millions of lives and
is being implemented by government
agencies, public and private health
organizations, Fortune 500, public
school districts, and families across the
United States and around the world.
A Serial Entrepreneur and
Prominent Innovator
Mr. Daniel A. Etra is the Co-founder
of Rethink and currently serves as its
CEO. He has over two decades of
international business experience,
including 15 years as a serial
entrepreneur.
Mr. Etra was previously the CEO of
R.E.R. International, which he also
co-founded. The company is a global
supplier of printed materials to the
retail industry. He has won numerous
awards including the Inc. 500 Award
and the SmartCEO Future 50 Award.
Mr. Etra is also a member of the Young
Presidents’ Organization (YPO). Born
and raised in New York City, he is
active in a variety of children’s causes
and volunteers with organizations such
as NY Cares and Memorial Sloan-
Kettering Cancer Center.
Helping Millions of Individuals
With roughly 450 million individuals
with a developmental disability
globally, there is a tremendous need for
Rethink. The company looks forward
to continuing to expand as the premier
program supporting this growing
population and their caregivers, no
matter where they are located around
the world. Rethink is also broadening
its services to help individuals with
developmental disabilities as they enter
adulthood, including initiatives aimed
at helping them find employment and
assisting them in the workplace.
We inspire and
empower
individuals with
developmental
disabilities and
those who support
them.
|August 2018 43

Pharma companies are also evaluating untapped markets.
Among the top emerging markets, BRIC economies
stand out the most with the probable addition of Mexico
and Turkey. While China is already competitive, the
others in the list are viewed as geographies with
tremendous opportunity.
However, growing economies have their own challenges.
Underdeveloped infrastructure and unique regulations
mean that entry and success in these markets are more
complex than they may seem. Seeking drug approvals in
different geographies also means that Pharma companies
will have to process multiple sets of clinical trials in each
country. With the probable exception of India, other
regions won’t have English as their language of choice
which makes language intervention an absolute
necessity.
The Increasing Involvement of China
The recent regulatory change in China has paved the way
for more globally accepted drugs to be launched in
China. However, they will still need to undergo the
regulatory process as usual. We expect an increased
effort from Pharma companies to launch more drugs in
China which is the second largest Pharmaceutical market
in the world. Biotech is also booming in China with the
help of conscious Government support. There seems to
be no shortage of investment either in this regard. Hence,
you can expect BioTech companies to have a keen
interest in expanding their focus to China in the coming
years. Based on this, we foresee the demand for
translation between English and Simplified Chinese to
rise in the near future. Also, it will be wiser for
companies to outsource their documentation
requirements since adhering to the stringent protocols in
Chinese will not be easy.
The Rising Influence of the Patients
As patients become more aware and educated about the
drugs they take, Pharma companies are forced to
The growth of China and Japan as leading
markets for the Pharma and Biotech industry has
made language an important factor for
companies looking to be successful in global markets.
Moreover, emerging markets in non-English speaking
countries such as Brazil, Russia and Turkey has only
increased the need for “Strategic Language
Partnerships”. Navigating through regulatory
requirements and Clinical Trial documentation in foreign
languages seem like a daunting task just from the sound
of it. An increasing number of companies prefer to
outsource the language requirements in order to speed up
approvals and decrease rejections.
With the current trends in the Pharma and Biotech
Markets, we suspect the need to only increase. There are
four definite areas that point towards the prominent role
of language in the coming years.
Emerging Markets have More Promise
Since established markets in US and Europe have very
little room for smaller players, SMEs are growing more
confident that growing markets are a better investment.
Pricing pressures and slower growth means that Big
4 TRENDS THAT
WILL MAKE
LANGUAGE
SOLUTIONS A BIG
PART OF
BIOTECH AND
GLOBALIZATION
August 2018|44

consider a patient-first business model to cope with their
dynamic expectations and demands. Companies are
considering smartphone apps and online portals to stay
connected with patients. With more sophisticated
technological options being made available with every
passing day, a range of health services can be offered to
patients at their convenience. These tools also serve as a
great way to acquire patient data, maintain them and gain
useful insight.
However, replicating this approach in other geographies
will need language support. App and Software
localization requires deep understanding of cultural
nuances in order to be executed successfully. Apart from
this, promotional and informational collateral also need
to be tailored and edited in order to appeal to consumers
in various geographies. This not only includes physical
collateral but also digital materials. Hence, as the focus
shifts to the patient, there is certainly a rise in demand
for language solutions expected from Pharma and
Biotech companies.
Managing the Digital Baggage
While e-pharmacies are still in their infancy, there is
enough reason to believe in their success in the near
future. Globalization plans for e-pharmacies, is a long
way away from being a topic of discussion. In the
meanwhile, Pharma and Biotech companies still need to
maintain their digital presence whose importance
continues to grow in the grand scheme of things. This
includes websites, social media positioning and online
reputation management (ORM) among others. In recent
times, we’ve received an increased demand for
translation of marketing materials from companies like
Abbott Healthcare and other Fortune 500 companies.
As pharma and biotech companies look to build their
presence across different geographies, they will need to
think about how they can take their digital assets along.
Maintaining brand positioning and brand image across
multiple regions is always going to be a challenge.
Moreover, failure to understand cultural nuances and
demand can be a cause for stunted growth. Companies
that have the foresight to see the importance of a
language solutions partner at this stage will have greater
chances to succeed in new geographies.
Shilpa Mittal, CEO of Ulatus,
Ulatus is one of the world’s
foremost language solutions
providers. Shilpa is honoured
with the prestigious “Best
Woman Entrepreneur 2017”
award by Golden Bridge in San
Francisco.
About the Author
Shilpa Mittal
CEO, Ulatus
|August 2018 45
Expert’s Outlook

Social Media
Marketing
he absence of pharma brands on social media creates a significant void of reputable healthcare information to aid
Tpatients,” writes Dawn Lacallade, LiveWorld's Chief Social Strategist.
Social media infiltrate virtually every facet of an individual's digital life. Today, patients are using social media as a major
source of information and healthcare research. Thus, it is essential that pharma companies should be present on social media
to provide full and accurate information to the consumers. To comprehend how social media can assist patients, it is crucial
to understand what compels people to use social media as a source of information.
Social media allows interaction among people which involves exchange and creation of information. It is the perfect conduit
for pharmaceutical companies to connect with their customers, patients and physicians.
According to the current FDA regulations, pharma companies are not able to easily join in a conversation to provide accurate
and balanced information. Regulations dictate that, in a single social post, brands are required to provide precise facts on the
benefits and hazards associated with conditions and products. Due to the character limitations on many social media
platforms, most pharma companies prefer to stay out of the conversation. This results in circulation of falsified information.
This information can be either marginally inaccurate or significantly harmful.
“
for
August 2018|46

Although the communication of pharmaceutical industries is highly
regulated, they are gradually adopting social media platforms to reach and
interact with consumers and healthcare professionals. Here are some of
the top social media practices to look out for:
Crafting Customer Experience
Several marketers think that their job is finished once the sales team
takes over, but in reality, it is just the beginning. The way people
experience your brand will impact the way they think about you, which
will have an enormous effect on the success of your company in
the long run. Devoting a part of the marketing budget to
nurture the existing clientele will make their experience
splendid and thus promote brand loyalty. It is also crucial
to respond whenever your brand in mentioned publicly,
whether positively or negatively, which will help
cultivate a strong and lasting relationship with your
customers. Younger generations are increasingly
withdrawing from traditional social media platforms
and adopting more innovative channels that are more
intimate in the way of communication. To keep up with
this challenge, companies need to find a way to automate the
process wherever possible.
Regulating Content
Pharma companies need to develop content marketing strategies that merge each
piece of content on every channel with their organization’s objectives and
customers’ needs. Creators need to have a clear business objective including the
value that will be delivered to distinct audiences. All companies need to have a
social media compliance officer who will work closely with a corporate legal
counsel and develop a complete strategy and decide if there will be consolidated
social media posting or if individual employees will have the consent to
participate. And lastly, it is critical that all employees understand their role in
corporate social media and be trained on the rules.
Overall Integration
Pharma companies should stop thinking about content marketing and social media as
add-ons. To boost their outcome for clients, content and social marketing need to be a part
of almost every program. To develop a fully integrated program, companies need to involve
influencers and content marketers during the initial stages. Implementing an organized
approach to content and moderation will not only optimize the processes, but also aid in assuring
authorities that all the bases are covered to protect and provide value for the brand.
Investing in Employees
An independent survey discovered that 72% of social media users expect response within an
hour from the brands they follow. This has caused brands to start heavily investing in cross-
functional social media teams that can keep up with the increasing number of client pings
|August 2018 47
Market Dashboard

every day. Encouraging and incentivizing team members to share brand messages on their own social media accounts, is
predicted to be a game-changer in the coming days. However this cannot be forced, it is essential for employees to want to
share company posts, and along with this the content has to resonate with their own audiences.
Influencer Marketing
Influencer marketing will continue to develop and become an even more established part of the strategy. Currently many
brands try influencer marketing and fail as it is not easy to find effective influencers. Additional data will help in selection
of the right influencers and analyze the results from influencer campaigns. Today, in healthcare, influencers are often
regular people. Some are directly affected by a disease or are being treated with a specific product, while others have
gained a lot of knowledge about a condition and are considered as Subject Matter Experts. The common trend is to select
someone who has an ever-increasing community of followers who value their opinion.
Numerous companies still think of social media as merely a marketing tool which is not true anymore. Consumers learn
about products on different social networks and seek customer service on messaging channels. Moreover, good
storytelling has always been an essential part of effective marketing. But social media is changing the way audiences
consume stories and pharma companies will be required to keep up with the evolution of social storytelling if they want to
remain relevant.
Yet there is still a note of caution with compliance being the foremost priority of pharmaceutical companies. But as
industries are starting to adopt social media without clear regulatory guidance, remaining compliant will be the main
challenge to face.
BUSINESS
MARK
ETING
August 2018|48

The repercussions of major healthcare policy changes
over the past decade continue to buffet the
healthcare services sector. There has been a domino
effect on the health of countless Americans and even on the
integrity of the healthcare payer system itself.
Recovery from this untenable situation hinges on agile,
adaptable, and innovative systems capable of handling both
current and future uncertainty. To address this need, the
world’s largest healthcare service providers are turning to
the range of services offered by Vee Technologies.
Leadership and Recognition
Vee Technologies is one of the world’s foremost global
strategic services companies. Founded in 2000, it operates
today from offices in New York and Bangalore, India.
The company has thrice made the prestigious Inc. 500’s list
of the fastest growing businesses in the United States.
Gartner included Vee Technologies in its 2017 and 2018
Market Guide for Healthcare Payers’ Core Administrative
Processing Solutions and its December 2016 Market Guide
to Key Customer Management BPO Service Providers.
Charting the company’s powerful strides into the world of
healthcare services is its CEO and Managing Director,
Chocko Valliappa.
With Chocko at the helm, Vee now counts three of the top
six insurance providers in the U.S. amongst its clients. The
company also caters to the needs of hundreds of hospitals,
including six of the top 10 medical institutions in the
country.
Simplifying Complexity
Vee Technologies appreciates that while its healthcare
services clients come from the same sector, their individual
needs and concerns can differ significantly.
The company’s experienced analysts take a systematic and
deliberate approach to ascertain and pinpoint the unique
challenges confronting each client. They then devise and
implement a strategy to address those specific concerns.
This is reinforced by an overall focus on improving revenue
generation, customer retention, error reduction, and
compliance.
A key differentiator of Vee Technologies is its emphasis on
achieving major change through minimal intervention. This
philosophy lies at the crux of the company’s consultation
services.
By applying its incisive ability to identify and remove
operational bottlenecks, clients are able to reinvigorate their
bottom line without reinventing their entire operations.
Vee Technologies:
Streamlined, Multi-faceted
Healthcare Management in
Your Hands
Chocko Valliappa
CEO & Managing Director
August 2018|50
The
Most Innovative
HEALTHCARE

The majority of such risks can be
countered and even circumvented with
the right IT infrastructure. However,
many companies are reluctant to invest
in IT because of the uncertainty that
the costs will offset the expected gains.
Vee Technologies eliminates the
uncertainty through accurate, detailed
audits. It uses these assessments as the
basis for reliable projections of real-
world impact and the ROI for every
investment.
These insights place clients in the best
position to make reliable decisions
about both the present and future
direction of their companies.
Leveraging Technology
While policy and regulation changes
can put healthcare operations in
disarray, service providers also have to
contend with the limitations of
technology. Common concerns range
from skills shortages to coding
resources incapable of handling
complex requirements.
The operational complications
notwithstanding, shortcomings in this
critical area can potentially expose
individual employees and the entire
organization to noncompliance
penalties.
A popular solution for some companies
is outsourcing. However, outsourcing
can spawn a host of problematic issues
itself. Some of the most concerning are
the associated loss of control and
oversight.
Vee Technologies circumvents this by
exclusively employing pre-approved,
top-tier professionals. It also leverages
the power of big data to identify
actionable trends and deploys
resources to maximize the returns from
that information.
Addressing Change
The healthcare services sector has seen
a marked shift from simple clinical
care to value-based care. This trend is
positive in itself but places
reimbursement pressures on virtually
every healthcare services provider. It
also fosters increased operational
complexity.
The only way to keep pace with such
change is through improved workflow
and internal processes.
Vee Technologies achieves this by
generating insights that allow clients to
increase reimbursements and improve
liquidity. Their solutions are a
combination of reduced AR
(anticipated reimbursement),
production costs, complexity, and
processed errors.
The looming specter of compliance
risks is another area of concern for
healthcare service providers. Such
risks may be unintentional, as with
genuine data collection and entry
errors or simple miscommunication.
However, factors like undetected fraud
and PHI disclosure entail serious
consequences.
This tactic transcends simple profit; it
is the basis on which Vee’s clients
formulate their approach to overall
population health. With the right
information, they can reorganize their
assets to deliver better care within
shorter timeframes.
Perfect Balance
One of the central tenets of business
success is maintaining the ideal
balance between profit and the quality
of products and/or services delivered.
In the healthcare industry, the stakes
are even higher because the care
provided dictates quality of life.
Tool complexity and convoluted Payor
rules detract from the time and effort
provided to patients. It is compounded
by missing reimbursements and
high AR.
Vee Technologies utilizes its industry
expertise and experience to combine
revenue cycle management with health
information management. This overlap
of technology, information, and
specialized knowledge gives its clients
the edge they need to overcome any
challenge.
With these powerful resources at their
fingertips, every Vee Technologies
client knows that it has the foundation
upon which to achieve more while
spending less. That sentiment
continues to be the driving force
behind the company’s popularity
and success.
Accuracy,
Competency,
and Teamwork
resulting in
Extraordinary
Outcomes.
|August 2018 51

The 10 most innovative healthcare solution providers 2018

The 10 most innovative healthcare solution providers 2018

Empfohlen

Empfohlen

Weitere ähnliche Inhalte

Was ist angesagt?

Was ist angesagt? (20)

Ähnlich wie The 10 most innovative healthcare solution providers 2018

Ähnlich wie The 10 most innovative healthcare solution providers 2018 (20)

Mehr von Insights success media and technology pvt ltd

Mehr von Insights success media and technology pvt ltd (20)

Kürzlich hochgeladen

Kürzlich hochgeladen (20)

The 10 most innovative healthcare solution providers 2018